The Hospice e-News
Week of October 19, 2006
…a service of
WHO DECIDES ON CPR FOR THE GRAVELY ILL?
The New York Times, in “The
Last Word on the Last Breath,” examines the legal and ethical complexities of
giving or withholding CPR for gravely ill patients. Physicians, patients and family
representatives all face challenges. The
physician may “believe that medical judgment about whether CPR will be
effective in a given patient’s case, and knowledge of the havoc it can wreak on
a dying body, should prevail.” The
patient may or may not have made his or her own wishes known and is in no
condition to now express them. The
patient’s representative may feel terrible guilt at refusing CPR and may
mistakenly believe, from watching television, that CPR is usually effective and
harmless.
CPR was
never intended to be “used routinely for very sick patients, for whom cardiac
arrest is expected.” Now in use for
about 40 years, CPR, says the article, “can be
successful in patients who have a sudden, unexpected heart attack or severe
respiratory distress. Research shows
that the “long-term survival for hospitalized patients who are given CPR is
about 15 percent” or less. On television
medical dramas, however, the long-term survival rate is 67%.
The
article relates a story from Dr. Daniel Sulmasy, now
an internist in
While the
above example is extreme, the article says, “the
question of who has final say over whether CPR should be attempted on a gravely
ill patient -- the doctor, the patient or the patient’s representative -- is
live and unsettled in law and medicine.”
Both states and hospitals have made attempts to clarify the issue, with
a resulting hodge-podge of guidelines that are confusing even to some state
judges.
*
*
*
*
* Many hospitals
have, in the past few years, “quietly developed policies underscoring that
doctors, not family members, should have the final authority to make these
medical decisions.”
There is
no question, says the article, that the goal of advance-care legislation and
hospital ethics policies is to “create dignity and transparency in end-of-life
decisions. They are also, the article
says, “intended to help insulate doctors from
lawsuits.” Dr. Robert V. Brody, chairman
of the ethics committee at
“Many
physicians and patient advocates say that casting these end-of-life
conversations as adversarial needlessly provokes tensions. Instead, they say, the focus should be on achieving
a goal of end-stage care that both sides can agree on.” The friction often arises when a patient who
has not specified a preference about resuscitation is near death and the
patient’s representative must make the decision. Dr. Joseph J. Fins, author of A Palliative Ethic of Care, says “Doctors
can fumble this most delicate of conversations.” Sometimes, they even “foster” the disputes by
indicating that one organ system may be improving, implying hope “when there is
nothing but the grim reality that the patient will die. Then all of a sudden we tell the family that
it’s futile and we’re surprised that they’re surprised.”
Decisions
about resuscitation are definitely stressful for patient representatives. Dr. Sulmasy studied
several cases where decision-makers refused to consent to DNR orders and found
that the stress of the decision was comparable to that of surviving a house
fire. He thinks that the recent
Dr. Fins calls focusing on DNR orders “misguided.” “DNR is a game plan for the last 15 minutes
of your life,” he said. “By planning for those last 15 minutes, we’re
distorting priorities. Instead of
talking about futility, we should be discussing what has utility, like pain management, comfort,
closure. Recasting the discussion has
led to turning irresolvable dilemmas into problems that can be addressed.” (The
New York Times, 10/10)
PAIN NOTES
* A study
published in a recent Annals of
Pharmacotherapy says that in spite of “an increased risk of cardiovascular
adverse events,” coxib therapy may be superior in
safety to nonselective NSAID therapy.
Patients who may qualify are those with “higher risks of GI
complications, lower risk of CVEs, and in whom
greater cost is not a restraint.” A
study reported in the American Journal of
Cardiology said drugs that do not injure the gut, such as low-dose opiates
or acetaminophen, may “minimize NSAID-medicated GI complications” in the
elderly and in patients with a history of GI bleeding. A second American
Journal of Cardiology article said that acetaminophen “appears to have a
more favorable cardiovascular and gastrointestinal safety profile” than NSAIDs in “individuals with an increased risk for cardiorenal effects from NSAIDs
(e.g., the elderly, and those with hypertension, cardiac disease, or gouty
nephropathy).” (Pain & Central Nervous System Week, 10/9)
* Researchers at a conference on pain recently
held in Baltimore say that the brains of men and women are different, partly
due to the role of sex hormones, and that men and women feel pain differently. The
* When the
JCAHO implemented pain-management guidelines in 2001,
HOSPICE AND PALLIATIVE CARE NOTES
* The patients
in the palliative care program at
* An article
in the Monterey County Herald
explains hospice and profiles Mari’Antonia Dudley, a
79-year-old hospice patient with COPD and congestive heart failure. Dudley says that, while she’s not very active
and spends most of her time reading or watching TV, she is independent and
content. She calls end-of-life care
“liberating” and recommends it to anyone who is terminally ill. (
* David Work,
executive director emeritus of the
*
RESEARCH AND RESOURCE NOTES
* An article
in the latest issue of Ethnicity and
Disease reports on a study of preferences for life-sustaining treatment
that shows a clear difference between black patients and white. Lead author, Dr. William Bayer, says that not
only do blacks and whites have different wishes, but the wishes of black
patients “are largely at odds with the prevailing ethic regarding end-of-life
care.” (Center for the Advancement of Health, 10/12)
* A
widely-reported study finds that the antipsychotic drugs used to calm agitated
Alzheimer’s patients help very few of them and frequently have side-effects. The NIH study suggests that most of the
patients would do just as well on placebos. This and another recent study reveal two
problems in the regulation and use of psychiatric drugs. The short-term trials “have limited value in
telling doctors how patients will fare overall, or whether newer drugs are
worth their higher cost.” The other
issue is “the extent to which physicians are prescribing and using medications
in the absence of empirical data to guide them.” (The
* Half of the
registered nurses who responded to a recent survey reported “chronic
interference of work with their home lives,” according to researchers at
OTHER NOTES
* From a
discussion in a bar in
* In 2005,
healthcare organizations had more voluntary employee turnover than companies in
other industries. The median healthcare
turnover was 14.1%, compared to 10.6% in all
* A new
report from the Government Accountability Office (GAO) says, “Key information
security controls were missing” from a communication network used by CMS. The identified weaknesses “could lead to
disruptions in services” to Medicare and Medicaid beneficiaries and that
“sensitive, personally identifiable information ‘could be improperly modified,
disclosed, or deleted.’” The GAO says
the system had no audit trails to determine who had used the network and “no
reliable way to detect intrusions into [the] computers.” (The
New York Times, 10/8)
Thanks to Ann Jackson for
contributions.
Glatfelter Insurance Group is the national
sponsor of Hospice News Network for 2006.
Glatfelter Insurance Group provides property and liability insurance for
hospices and home healthcare agencies through their Hospice and Community Care
Insurance Services division. Ask your
insurance agent to visit their website at www.hccis.com.